Page last updated: 2024-08-22

sodium selenate and morphinans

sodium selenate has been researched along with morphinans in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balboni, G; Bidlack, JM; Knapp, BI; Lazarus, LH; Neumeyer, JL; Peng, X; Salvadori, S; Trapella, C1
Bidlack, JM; Knapp, BI; Neumeyer, JL; Peng, X1
Bidlack, JM; Decker, M; Fulton, BS; Knapp, BI; Neumeyer, JL; Zhang, B1
Bidlack, JM; Decker, M; Knapp, BI; Neumeyer, JL; Si, YG1
Bidlack, JM; Fulton, BS; Knapp, BL; Neumeyer, JL1
Bidlack, JM; Neumeyer, JL; Scrimale, T; Sromek, AW; Zhang, B; Zhang, T1

Other Studies

6 other study(ies) available for sodium selenate and morphinans

ArticleYear
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores.
    Journal of medicinal chemistry, 2006, Sep-07, Volume: 49, Issue:18

    Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Dipeptides; Ligands; Morphinans; Narcotic Antagonists; Radioligand Assay; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Tetrahydroisoquinolines

2006
Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
    Journal of medicinal chemistry, 2007, May-03, Volume: 50, Issue:9

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; CHO Cells; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Morphinans; Nalbuphine; Naloxone; Naltrexone; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship

2007
Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.
    Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

    Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Hydrolysis; Ligands; Morphinans; Protein Binding; Receptors, Opioid

2009
Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.
    Journal of medicinal chemistry, 2010, Jan-14, Volume: 53, Issue:1

    Topics: Binding Sites; Ligands; Molecular Conformation; Morphinans; Narcotic Antagonists; Structure-Activity Relationship

2010
Effect of linker substitution on the binding of butorphan univalent and bivalent ligands to opioid receptors.
    Bioorganic & medicinal chemistry letters, 2010, Mar-01, Volume: 20, Issue:5

    Topics: Analgesics; Animals; CHO Cells; Cricetinae; Cricetulus; Ligands; Morphinans; Protein Binding; Receptors, Opioid, kappa; Receptors, Opioid, mu

2010
Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.
    Bioorganic & medicinal chemistry, 2011, May-01, Volume: 19, Issue:9

    Topics: Animals; Butorphanol; CHO Cells; Cricetinae; Cricetulus; Decanoates; Humans; Ligands; Morphinans; Protein Binding; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

2011